Jan 12 (Reuters) - Irongate Group (IAP) : IRONGATE GROUP - IRONGATE GROUP REJECTS REVISED INDICATIVE PROPOSAL FROM 360 CAPITAL IRONGATE GROUP - IAP BOARD HAS UNANIMOUSLY CONCLUDED THAT REVISED INDICATIVE PROPOSAL CONTINUES TO UNDERVALUE IAP
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status